Thoracic Key

Transcatheter Aortic Valve Replacement Introduction Aortic stenosis (AS) affects morbidity and mortality as populations continue to age. Recent studies have estimated the prevalence of calcific AS between 2% and 4%…

Introduction The Conformable TAG (CTAG) endoprosthesis (WL Gore and Associates, Flagstaff, Arizona) is the third-generation thoracic endograft approved for treatment of aneurysm, traumatic transection, and Type B dissection in the…

Introduction and Background The introduction of thoracic stent grafts into clinical practice over the past two decades and the ability to image the thoracic aorta in high definition have offered…

Introduction Since its inception in 1992, thoracic endovascular aortic repair (TEVAR) was introduced as an alternative treatment option to conventional open surgery for patients with complicated Type B aortic dissection…

Introduction Bolton Medical (Sunrise, Florida), now owned by Terumo (Tokyo, Japan), introduced the Relay thoracic endovascular aortic repair (TEVAR) endograft in 2005, with Phase II trials for approval in the…

Introduction The common goal of catheter-based embolization procedures is to cease the flow of blood mechanically in a particular vessel or vascular territory using either a temporary or permanent agent….

Endovascular repair of thoracoabdominal aortic aneurysms requires long segment stent graft coverage with concomitant revascularization of the renovisceral and potentially supraaortic arch segments. Such procedures represent the highest extent of…

Introduction Endovascular fenestration is used to manage complicated aortic dissection in a manner analogous to open surgical septectomy. The intent to create a large communication between the aortic true and…

Introduction Thoracic endovascular aortic repair (TEVAR), first performed in 1992, has become the treatment of choice for the majority of thoracic aortic pathologies, including thoracic aortic aneurysms (TAAs) and complicated…